Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gülsenay Citirak"'
Publikováno v:
PLoS ONE, Vol 11, Iss 10, p e0164092 (2016)
The aim of this observational, cross-sectional study was to quantify the potential presence of muscle weakness among patients with generalized myasthenia gravis (gMG). The influence of gender, treatment intensity and disease duration on muscle streng
Externí odkaz:
https://doaj.org/article/75de31d2e6c64b358902566475e46ab3
Publikováno v:
Citirak, G, Malmqvist, L & Hamann, S 2022, ' Analysis of Systemic Risk Factors and Post-Insult Visual Development in a Danish Cohort of Patients with Nonarteritic Anterior Ischemic Optic Neuropathy ', Clinical Ophthalmology, vol. 16, pp. 3415-3424 . https://doi.org/10.2147/OPTH.S384740
Gülsenay Citirak, Lasse Malmqvist, Steffen Hamann Department of Ophthalmology, Rigshospitalet, University of Copenhagen, Glostrup, DenmarkCorrespondence: Steffen Hamann, Department of Ophthalmology, Rigshospitalet, University of Copenhagen, Valdem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fd5b8b3cffd1e3b606d8d70d26496c6
https://doi.org/10.2147/opth.s384740
https://doi.org/10.2147/opth.s384740
Autor:
Kira Philipsen Prahm, Ulrich Lindberg, Sebastian von Huth, Thomas Krag, Christina Kruuse, John Vissing, Bo Nyhuus, Stine J. Lundgaard, Gülsenay Citirak, Nanna Witting, Niels Vejlstrup
Publikováno v:
Annals of Neurology. 76:550-557
Objective Patients with Becker muscular dystrophy (BMD) and Duchenne muscular dystrophy lack neuronal nitric oxide synthase (nNOS). nNOS mediates physiological sympatholysis, thus ensuring adequate blood supply to working muscle. In mice lacking dyst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68939062c24429bf90af2dea1151aa7d
https://doi.org/10.1002/ana.24216
https://doi.org/10.1002/ana.24216
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 10, p e0164092 (2016)
Citirak, G, Cejvanovic, S, Andersen, H & Vissing, J 2016, ' Effect of Gender, Disease Duration and Treatment on Muscle Strength in Myasthenia Gravis ', PLOS ONE, vol. 11, no. 10, e0164092 . https://doi.org/10.1371/journal.pone.0164092
PLoS ONE, Vol 11, Iss 10, p e0164092 (2016)
Citirak, G, Cejvanovic, S, Andersen, H & Vissing, J 2016, ' Effect of Gender, Disease Duration and Treatment on Muscle Strength in Myasthenia Gravis ', PLOS ONE, vol. 11, no. 10, e0164092 . https://doi.org/10.1371/journal.pone.0164092
INTRODUCTION: The aim of this observational, cross-sectional study was to quantify the potential presence of muscle weakness among patients with generalized myasthenia gravis (gMG). The influence of gender, treatment intensity and disease duration on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b969d73f6042d33bf6cb0a9841be363d
http://europepmc.org/articles/PMC5065212
http://europepmc.org/articles/PMC5065212
Publikováno v:
Neurology. 85(5)
To investigate the effect of regular aerobic training and postexercise protein-carbohydrate supplementation in patients with facioscapulohumeral muscular dystrophy (FSHD).In this randomized, double-blind, placebo-controlled parallel study, we randomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bcd4c35ce4146d4d803726c1bb88668
https://pubmed.ncbi.nlm.nih.gov/26156510
https://pubmed.ncbi.nlm.nih.gov/26156510
Publikováno v:
Neuromuscular Disorders. 23:824-825
In healthy subjects, regular exercise is beneficial for mental and physical health, and post-exercise protein supplementation has been shown to enhance the physiological responses to training. FSHD is a muscular dystrophy characterized by slow progre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b620103eb516721c86fcf24899a9dfa
https://doi.org/10.1016/j.nmd.2013.06.645
https://doi.org/10.1016/j.nmd.2013.06.645